Amanda M. Brandow

Amanda M. Brandow

Auto-generated profile, based on publicly available information

Amanda M. Brandow

Section of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
ABAmanda M. Brandow
Amanda M. Brandow
CCC. Patrick Carroll
C. Patrick Carroll
SCSusan Creary
Susan Creary
RERonisha Edwards-Elliott
Ronisha Edwards-Elliott
JGJeffrey Glassberg
Jeffrey Glassberg
ELEddy Lang
Eddy Lang
Background: The management of acute and chronic pain for individuals living with sickle cell disease (SCD) is a clinical challenge. This reflects the paucity of clinical SCD pain research and limited understanding of the complex biological differences between acute and chronic pain. These issues collectively create barriers to effective, targeted interventions. Optimal pain management requires interdisciplinary care.Objective: These evidence-based guidelines developed by the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in pain management decisions for children and adults with SCD.Methods: ASH formed a multidisciplinary panel, including 2 patient representatives, that was thoroughly vetted to minimize bias from conflicts of interest. The Mayo Evidence-Based Practice Research Program supported the guideline development process, including updating or performing systematic reviews. Clinical questions and outcomes were prioritized according to importance for clinicians and patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used, including GRADE evidence-to-decision frameworks, to assess evidence and make recommendations, which were subject to public comment.Results: The panel reached consensus on 18 recommendations specific to acute and chronic pain. The recommendations reflect a broad pain management approach, encompassing pharmacological and nonpharmacological interventions and analgesic delivery.Conclusions: Because of low-certainty evidence and closely balanced benefits and harms, most recommendations are conditional. Patient preferences should drive clinical decisions. Policymaking, including that by payers, will require substantial debate and input from stakeholders. Randomized controlled trials and comparative-effectiveness studies are needed for chronic opioid therapy, nonopioid therapies, and nonpharmacological interventions.

26 September 2012 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
ABAmanda M. Brandow
Amanda M. Brandow
CSCheryl L. Stucky
Cheryl L. Stucky
CHCheryl A. Hillery
Cheryl A. Hillery
RHRaymond G. Hoffmann
Raymond G. Hoffmann
JPJulie A. Panepinto
Julie A. Panepinto
Sickle cell disease (SCD) pain is associated with colder temperatures and touch and described as “cold,” “hot,” and “shooting” suggesting hypersensitivity to tactile stimuli. Sickle mice exhibit hypersensitivity to thermal (cold, heat) and mechanical stimuli compared to controls. It is unknown whether humans experience this same hypersensitivity. Thus, we quantified thermal and mechanical sensitivity differences between patients with SCD and controls. Our primary hypothesis was that patients with SCD will exhibit hypersensitivity to thermal and mechanical stimuli compared to race‐matched controls. Our secondary hypothesis was this hypersensitivity will be associated with older and female subjects, and with frequent pain and hemolysis in patients with SCD. A total of 55 patients and 57 controls ≥7 years completed quantitative sensory testing. Patients with SCD detected the sensation of cold and warm temperatures sooner as seen in their significantly lower median cold and heat detection thresholds [29.5°C vs. 28.6°C, P = 0.012 and 34.5°C vs. 35.3°C, P = 0.02] and experienced cold and heat pain sooner as seen in their significantly lower median cold and heat pain thresholds [21.1°C vs. 14.8°C, P = 0.01 and 42.7°C vs. 45.2°C, P = 0.04]. We found no mechanical threshold differences. Older age was associated with lower cold, heat, and mechanical pain thresholds in both groups. No association with pain, gender, or hemolysis was found. Patients with SCD exhibit hypersensitivity to thermal stimuli suggesting peripheral or central sensitization may exist and could contribute to SCD pain. Am. J. Hematol. 2013.

26 October 2013 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
ABAmanda M. Brandow
Amanda M. Brandow
RFRebecca A. Farley
Rebecca A. Farley
JPJulie A. Panepinto
Julie A. Panepinto

1 June 2010 in Expert Review of Hematology
Verified
Journal Article
Closed access
ABAmanda M Brandow
Amanda M Brandow
JPJulie A Panepinto
Julie A Panepinto
Sickle cell disease (SCD) is the most common inherited blood disorder in the USA, affecting approximately 89,000 Americans or one in 400 African–Americans [1]. SCD is caused by inheritance of the s...

30 April 2010 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
ABAmanda M. Brandow
Amanda M. Brandow
DJDanielle L. Jirovec
Danielle L. Jirovec
JPJulie A. Panepinto
Julie A. Panepinto
Click on the article title to read more.

3 August 2009 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
ABAmanda M. Brandow
Amanda M. Brandow
DBDavid C. Brousseau
David C. Brousseau
NPNicholas M. Pajewski
Nicholas M. Pajewski
JPJulie A. Panepinto
Julie A. Panepinto